These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Plasminogen activation in human acute leukaemias. Scherrer A; Wohlwend A; Kruithof EK; Vassalli JD; Sappino AP Br J Haematol; 1999 Jun; 105(4):920-7. PubMed ID: 10554801 [TBL] [Abstract][Full Text] [Related]
3. Plasminogen activator in acute myeloid leukaemic marrows: u-PA in contrast to t-PA in normal marrow. McWilliam N; Robbie L; Booth N; Bennett B Br J Haematol; 1998 Jun; 101(4):626-31. PubMed ID: 9674732 [TBL] [Abstract][Full Text] [Related]
4. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes. Rość D; Kremplewska-Nalezyta E; Gadomska G; Zastawna E; Michalski A; Drewniak W Med Sci Monit; 2000; 6(4):684-91. PubMed ID: 11208392 [TBL] [Abstract][Full Text] [Related]
5. Interferon production in myelo- and lymphoproliferative diseases. I. Spontaneous interferon production in acute and chronic leukaemias. Szabó B; Tóth FD; Kiss J; Váczi L; Kiss A; Rák K Acta Microbiol Hung; 1988; 35(3):295-300. PubMed ID: 2465655 [TBL] [Abstract][Full Text] [Related]
6. Stimulation of tissue type plasminogen activator by leukaemic cell homogenates. Wada H; Kumeda Y; Ogasawara Z; Minamikawa K; Wakita Y; Nakase T; Kaneko T; Ohiwa M; Kageyama S; Kobayashi T Blood Coagul Fibrinolysis; 1993 Aug; 4(4):591-7. PubMed ID: 8218856 [TBL] [Abstract][Full Text] [Related]
7. The bleeding disorder in acute promyelocytic leukaemia: fibrinolysis due to u-PA rather than defibrination. Bennett B; Booth NA; Croll A; Dawson AA Br J Haematol; 1989 Apr; 71(4):511-7. PubMed ID: 2496742 [TBL] [Abstract][Full Text] [Related]
8. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. Druker BJ; Sawyers CL; Kantarjian H; Resta DJ; Reese SF; Ford JM; Capdeville R; Talpaz M N Engl J Med; 2001 Apr; 344(14):1038-42. PubMed ID: 11287973 [TBL] [Abstract][Full Text] [Related]
9. Heparin reverses Rhodamine 123 extrusion by multidrug resistant cells. Maia RC; Wagner K; Cabral RH; Rumjanek VM Cancer Lett; 1996 Aug; 106(1):101-8. PubMed ID: 8827053 [TBL] [Abstract][Full Text] [Related]
10. Rearrangement of immunoglobulin and T cell receptor genes in acute and chronic leukaemias. Liang R; Chan VV; Chan TK; Chiu E; Todd D Acta Haematol; 1991; 85(2):71-5. PubMed ID: 1850943 [TBL] [Abstract][Full Text] [Related]
11. Expression of the leptin receptor in human leukaemic blast cells. Nakao T; Hino M; Yamane T; Nishizawa Y; Morii H; Tatsumi N Br J Haematol; 1998 Aug; 102(3):740-5. PubMed ID: 9722301 [TBL] [Abstract][Full Text] [Related]
12. Soluble urokinase receptor levels correlate with number of circulating tumor cells in acute myeloid leukemia and decrease rapidly during chemotherapy. Mustjoki S; Sidenius N; Sier CF; Blasi F; Elonen E; Alitalo R; Vaheri A Cancer Res; 2000 Dec; 60(24):7126-32. PubMed ID: 11156421 [TBL] [Abstract][Full Text] [Related]
13. Expression and distribution of aphidicolin-induced fragile sites in chronic myeloid leukaemia, acute lymphocytic leukaemia and acute myeloid leukaemia. Stopera SA; Ray M Cytobios; 1989; 60(241):103-9. PubMed ID: 2517248 [TBL] [Abstract][Full Text] [Related]
14. Stimulating capacity of blast cells from patients with chronic myelocytic leukaemia, in blastic crisis in 'one-way' mixed lymphoycte reaction: lack of evidence for T lymphoblastic conversion. Han T; Gomez GA; Minowada J Immunology; 1978 Aug; 35(2):299-305. PubMed ID: 155646 [TBL] [Abstract][Full Text] [Related]
15. Expression of interferon regulatory factor 4 in chronic myeloid leukemia: correlation with response to interferon alfa therapy. Schmidt M; Hochhaus A; König-Merediz SA; Brendel C; Proba J; Hoppe GJ; Wittig B; Ehninger G; Hehlmann R; Neubauer A J Clin Oncol; 2000 Oct; 18(19):3331-8. PubMed ID: 11013272 [TBL] [Abstract][Full Text] [Related]
16. Analysis of the TNF receptors on human leukaemia cells by affinity cross-linking. Elbaz O; Mahmoud LA; Touw IP; Löwenberg B Br J Haematol; 1992 Aug; 81(4):530-2. PubMed ID: 1327064 [TBL] [Abstract][Full Text] [Related]
17. Concomitant secretion of prourokinase and of a plasminogen activator-specific inhibitor by cultured human monocytes-macrophages. Vassalli JD; Dayer JM; Wohlwend A; Belin D J Exp Med; 1984 Jun; 159(6):1653-68. PubMed ID: 6374011 [TBL] [Abstract][Full Text] [Related]
18. Tandem duplication of the FLT3 gene is found in acute lymphoblastic leukaemia as well as acute myeloid leukaemia but not in myelodysplastic syndrome or juvenile chronic myelogenous leukaemia in children. Xu F; Taki T; Yang HW; Hanada R; Hongo T; Ohnishi H; Kobayashi M; Bessho F; Yanagisawa M; Hayashi Y Br J Haematol; 1999 Apr; 105(1):155-62. PubMed ID: 10233379 [TBL] [Abstract][Full Text] [Related]
20. The characterisation of leukaemias with the Sysmex NE-8000. van der Meer W; Swinkels DW; Willems HL Acta Haematol; 1997; 98(4):195-8. PubMed ID: 9401496 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]